ABVC BioPharma News

ABVC BioPharma | 8-K: Current report

Apr 19 17:30 ET

ABVC BioPharma | 8-K: Current report

Apr 17 08:34 ET

ABVC BioPharma | 424B4: Prospectus

Apr 5 14:49 ET

ABVC BioPharma | EFFECT: Others

Apr 2 06:09 ET

ABVC BioPharma | 8-K: Current report

Mar 26 08:39 ET

ABVC BioPharma | DEFA14A: Others

Mar 25 16:35 ET

ABVC BioPharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Mar 22 17:04 ET

ABVC BioPharma | 10-K/A: Annual report (Amendment)

Mar 15 12:53 ET

ABVC BioPharma | DEFA14A: Others

Mar 14 12:14 ET

ABVC BioPharma | 8-K: Current report

Mar 14 11:39 ET

ABVC BioPharma | 8-K: Current report

Mar 14 09:09 ET

ABVC BioPharma | 10-K: Annual report

Mar 13 17:20 ET

ABVC BioPharma | 8-K/A: Current report (Amendment)

Feb 29 16:40 ET

ABVC BioPharma | 8-K/A: Current report (Amendment)

Feb 29 16:40 ET

ABVC BioPharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 16 17:08 ET

ABVC BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.

Feb 13 20:01 ET

ABVC BioPharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 9 17:10 ET

ABVC BioPharma | 8-K: Current report

Feb 8 09:35 ET

ABVC BioPharma | 8-K/A: Current report (Amendment)

Jan 26 12:11 ET

ABVC BioPharma | 8-K/A: Current report (Amendment)

Jan 17 00:00 ET